Bellwether Investment Group’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Bellwether Investment Group’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-350	Closed	–	–	1030
2016 Q4	$0	Buy	+350	New	+$27	﹤0.01%	1004
2016 Q2	$0	Buy	+350	New	+$133	﹤0.01%	676

Other funds holding PVCT

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Bellwether Investment Group's PVCT Position: Q1 2017 in Review

Bellwether Investment Group sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q1 2017, closing a stake of 350 shares.

Bellwether Investment Group first reported a position in PVCT in Q2 2016 and held it in 2 quarters. The position peaked at $0 in Q4 2016. 3 funds tracked by Wall St. Rank hold PVCT as of Q1 2017.

Bellwether Investment Group reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q1 2017 after selling out during the quarter.
Bellwether Investment Group sold 350 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q1 2017.
Bellwether Investment Group first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2016 and held it in 2 quarters.
Bellwether Investment Group's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $0 in Q4 2016.
3 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q1 2017.

Based on Bellwether Investment Group's 13F filing for Q1 2017, filed 12 May 2017.